CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases

Objective—Although endothelial progenitor cells (EPCs) have been reported to promote neovessel formation during vascular injury, the function of supporting cells of EPCs and their interaction with EPCs during EPC isolation remain unclear. Approach and Results—We investigated the functional properties of 2 types of EPCs, also known as endothelial colony-forming cells (ECFCs), CD34−/CD34+ cell–derived ECFCs (hybrid-dECFCs) and CD34+ cell–derived ECFCs (stem-dECFCs), isolated using different methods, to elucidate the role of CD34− cell populations as cell-supporting niches. Using EPC colony-forming and insert coculture assays, we found that CD34− accessory cells dynamically modulate hematopoietic stem cell–derived endothelial cell progenitor commitment via angiogenic cytokines secreted by CD34−/CD11b+ macrophages. On the basis of these findings, we isolated 2 types of ECFCs and investigated their bioactivities. We found that stem-dECFCs showed remarkably retarded cell growth, enhanced senescence, and decreased characteristics of ECFCs, whereas hybrid-dECFCs showed greater proliferative properties but delayed senescence. In a murine hind-limb ischemia model, hybrid-dECFCs showed significantly enhanced blood perfusion, capillary density, transplanted cell survival and proliferation, and angiogenic cytokine secretion compared with stem-dECFCs. In particular, the migratory capacity of hybrid-dECFCs was significantly enhanced, in part mediated via an augmented phosphorylation cascade of focal adhesion kinase and Src, resulting in a highly increased incorporation capacity of hybrid-dECFCs compared with stem-dECFCs. CD34− accessory cells of hybrid-dECFCs might be niche-supporting cells that facilitate cell survival, increase the secretion of angiogenic cytokines, and increase incorporation. Conclusions—This study provided important insight into blood vessel formation and repair in ischemic diseases for ECFC-based cell therapy.

[1]  T. Suda,et al.  Two anatomically distinct niches regulate stem cell activity. , 2012, Blood.

[2]  Joseph M. Scandura,et al.  Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells. , 2012, Blood.

[3]  S. Dimmeler,et al.  Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use , 2012, Circulation research.

[4]  Lei Ding,et al.  Endothelial and perivascular cells maintain haematopoietic stem cells , 2011, Nature.

[5]  E. J. Lee,et al.  Human peripheral blood-born hematosphere as a niche for hematopoietic stem cell expansion , 2011, Cell Research.

[6]  A. Zeiher,et al.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) , 2002, Clinical research in cardiology : official journal of the German Cardiac Society.

[7]  Sufen Guo,et al.  Endothelial Progenitor Cells Derived From CD34+ Cells Form Cooperative Vascular Networks , 2010, Cellular Physiology and Biochemistry.

[8]  L. Bidaut,et al.  Human CD34+ Cells in Experimental Myocardial Infarction: Long-Term Survival, Sustained Functional Improvement, and Mechanism of Action , 2010, Circulation research.

[9]  Douglas Losordo,et al.  Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. , 2010, Microvascular research.

[10]  Shahin Rafii,et al.  Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors , 2010, Nature Reviews Cancer.

[11]  C. Bokemeyer,et al.  TAE226-mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesis , 2010, Investigational New Drugs.

[12]  T. Yamanaka,et al.  Intramuscular Transplantation of G‐CSF‐Mobilized CD34+ Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single‐Blinded, Dose‐Escalation Clinical Trial , 2009, Stem cells.

[13]  E. Shpall,et al.  Ex vivo expansion of cord blood , 2009, Bone Marrow Transplantation.

[14]  Douglas Losordo,et al.  The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia , 2009, Journal of cellular physiology.

[15]  M. Eguchi,et al.  Pivotal Role of Lnk Adaptor Protein in Endothelial Progenitor Cell Biology for Vascular Regeneration , 2009, Circulation research.

[16]  F. Timmermans,et al.  Endothelial progenitor cells: identity defined? , 2008, Journal of cellular and molecular medicine.

[17]  S. Ramin,et al.  Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long‐term ex vivo culture , 2008, Transfusion.

[18]  B. Garmy-Susini,et al.  Integrins in angiogenesis and lymphangiogenesis , 2008, Nature Reviews Cancer.

[19]  M. Cavazzana‐Calvo,et al.  Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia , 2008, Modern Pathology.

[20]  Sean J. Morrison,et al.  Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life , 2008, Cell.

[21]  Douglas Losordo,et al.  Endothelial progenitor cells for cardiovascular regeneration. , 2008, Trends in cardiovascular medicine.

[22]  Ju-Young Kim,et al.  Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies , 2007, Circulation.

[23]  H. Masuda,et al.  Estrogen-Mediated Endothelial Progenitor Cell Biology and Kinetics For Physiological Postnatal Vasculogenesis , 2007, Circulation research.

[24]  H. Sevestre,et al.  Histological changes after implantation of autologous bone marrow mononuclear cells for chronic critical limb ischemia , 2007, Bone Marrow Transplantation.

[25]  J. Prchal,et al.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. , 2007, Blood.

[26]  K. Moore,et al.  Stem Cells and Their Niches , 2006, Science.

[27]  G. Nickenig,et al.  CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.

[28]  Hyun-Jai Cho,et al.  Cytokines and Matrix Metalloproteinases Progenitor Cells and Late Outgrowth Endothelial Cells: the Role of Angiogenic Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Ou , 2022 .

[29]  K. Pollok,et al.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.

[30]  T. Asahara,et al.  Endothelial progenitor cell culture for vascular regeneration. , 2004, Stem cells and development.

[31]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Stefanie Dimmeler,et al.  Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells , 2003, Circulation.

[33]  Shahin Rafii,et al.  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003, Nature Medicine.

[34]  R. Hartley,et al.  CD34− Blood‐Derived Human Endothelial Cell Progenitors , 2001, Stem cells.

[35]  W. Daniel,et al.  Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. , 2001, Cardiovascular research.

[36]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[38]  M. Ogawa,et al.  Stochastic model revisited. , 1999, International journal of hematology.

[39]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[40]  S. Hemmerich,et al.  Binding of L-selectin to the vascular sialomucin CD34. , 1993, Science.

[41]  M. L. Beau,et al.  Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. , 1992, Genomics.

[42]  I. Bernstein,et al.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors , 1986 .

[43]  L. Lajtha.  Stem cell concepts. , 1979, Nouvelle revue francaise d'hematologie.

[44]  R. Schofield.  The relationship between the spleen colony-forming cell and the haemopoietic stem cell. , 1978, Blood cells.